Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Breast × Clear all

NCT02802423 2026-04-13

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

Phase 1/2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07494448 2026-03-27

JAZMINE

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07441889 2026-03-02

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Phase 1/2 Not yet recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

Phase 1/2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07370506 2026-01-29

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07341737 2026-01-15

SL-28 for Advanced Solid Tumours

Phase 1/2 Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07339176 2026-01-14

OP-NEU-101

Phase 1/2 Not yet recruiting

BreastDermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms

NCT07336771 2026-01-13

JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07136428 2025-12-19

ASCENdANT

Phase 1/2 Not yet recruiting

HER2+ Metastatic Breast Cancer

NCT07292142 2025-12-18

FRIDA

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07260058 2025-12-02

Immune Cell Therapy for Advanced Solid Tumors

Phase 1/2 Not yet recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT07189884 2025-09-24

Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy

Phase 1/2 Not yet recruiting

Locally Advanced Breast Cancer (LABC)

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Phase 1/2 Not yet recruiting

BreastOther solid neoplasm

HER2+ Advanced Breast Cancer

NCT07177950 2025-09-17

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Phase 1/2 Not yet recruiting

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

NCT07173556 2025-09-15

A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer

Phase 1/2 Not yet recruiting

Advanced Breast Cancer

NCT05806385 2025-09-09

LOGIC

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT07161791 2025-09-09

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Phase 1/2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07139470 2025-08-24

Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT04480619 2025-07-16

Shiva

Phase 1/2 Not yet recruiting

Angiogenic Breast Cancer

NCT07067307 2025-07-16

Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06788197 2025-03-26

A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06775236 2025-03-19

Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT05821686 2025-02-12

Efficacy of Interleukin-2 in Triple Negative Breast Cancer

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT06757335 2025-01-03

A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06531486 2024-08-01

A Study of XS-02 Capsules in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04469127 2024-04-10

Heroine01

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT05986071 2024-03-29

MATRIX

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06140576 2023-11-20

The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06078670 2023-10-12

PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

BreastGastrointestinal

Intestinal Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06023277 2023-09-05

A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT05519670 2022-08-29

CAPRICE

Phase 1/2 Not yet recruiting

Breast Neoplasms